Simpler Grants.gov #HT942526PRMRPPCTA

Army Medical Research Program Solicitation for Platform Clinical Translation Award

This opportunity from the Dept. of the Army -- USAMRAA supports translational development and early-phase clinical trials for clinical technologies under the FY26 Peer Reviewed Medical Research Program Platform Clinical Translation Award. - Government Buyer: - Dept. of the Army - US Army Medical Research Acquisition Activity (USAMRAA) - Congressionally Directed Medical Research Programs (CDMRP) as funding entity - Products/Services Requested: - Research and development services for broadly applicable clinical technologies - Must address urgent and complex needs in two congressionally directed FY26 PRMRP topic areas - Platform product must align with PRMRP portfolio-specific strategic goals and military health care needs - Unique Requirements: - Multiple Principal Investigators permitted - PI-convened external advisory board required, including patient advocate participation - Maximum period of performance is 4 years - No cost sharing or matching required - Cooperative agreement or grant as funding instrument - Funding Details: - Approximately $30 million available for two awards - Each award capped at $15 million total cost - OEMs and Vendors: - No specific OEMs or vendors named; this is a grant solicitation for research and development

Description

The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports translational development and/or early-phase clinical trials for broadly applicable clinical technologies addressing urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product should address one of the FY26 PRMRP portfolio-specific strategic goals and the health care needs of military Service Members, Veterans, and their Families. The award allows for multiple Principal Investigators and requires a PI-convened external advisory board with patient advocate participation. Approximately $30 million is expected to fund two awards with total cost caps of $15 million per award over a maximum period of 4 years.

View original listing